PRMT1 Antibodies

Santa Cruz Biotechnology features a diverse variety of PRMT1 monoclonal antibodies for investigating protein arginine methyltransferase 1 (PRMT1) in various biological processes. PRMT1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PRMT1 is a key enzyme involved in the methylation of arginine residues on proteins, which plays a critical role in regulating gene expression, signal transduction, and cellular differentiation. PRMT1 dysregulation has been implicated in various diseases, including cancer and neurodegenerative disorders, making it a significant target for therapeutic intervention. Understanding the function and regulation of PRMT1 is essential for advancing knowledge of cellular processes and developing potential treatments. PRMT1 monoclonal antibodies enable precise detection and characterization of PRMT1 expression patterns and interactions. PRMT1 monoclonal antibodies support detailed mapping of protein methylation networks and their biological significance. PRMT1 monoclonal antibodies from Santa Cruz Biotechnology empower researchers worldwide to advance scientific understanding of protein methylation and its impact on human health.